SUPN earnings
Supernus Pharmaceuticals (SUPN) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- SUPN beat EPS estimates in 9 of its last 9 reports.
SUPN earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Oct 29, 2026 | 1.32 | 1.06 | 24.53% | $356.00M |
| Q2 2026 | Aug 3, 2026 | 1.15 | 0.87 | 32.34% | $343.00M |
| Q1 2026 | May 5, 2026 | 0.96 | 0.64 | 50.00% | $317.00M |
| Q4 2025 | Feb 24, 2026 | 0.82 | 0.65 | 26.15% | $357.00M |
| Q3 2025 | Nov 4, 2025 | 0.72 | 0.38 | 89.47% | $314.00M |
| Q2 2025 | Aug 5, 2025 | 0.51 | 0.26 | 96.15% | $302.00M |
| Q1 2025 | May 6, 2025 | 0.38 | – | – | $266.00M |
| Q4 2024 | Feb 25, 2025 | 0.32 | 0.32 | 0.00% | $298.00M |
| Q3 2024 | Nov 4, 2024 | 0.16 | – | – | $307.00M |
| Q2 2024 | Aug 6, 2024 | -0.72 | – | – | $299.00M |
| Q1 2024 | May 8, 2024 | 0.45 | – | – | $284.00M |
| Feb 27, 2024 | 0.43 | 0.28 | 53.57% | $300.65M | |
| Nov 8, 2023 | 0.34 | 0.30 | 13.33% | $261.20M |